Introduction:Embarking on the journey of pregnancy involves a multitude of considerations, and for women exploring the potential benefits of GLP-1 medications for weight loss, understanding the implications during pregnancy becomes
In the pivotal semaglutide trial, participants titrated up to a target dose and lost, on average, 14.9 percent of their body weight over 68 weeks, per the STEP 1 trial reported in the New England Journal of Medicine, 2021
At Allure Esthetic, our weight loss providers can help you through this process and create an easy process for everything you need.
They are not FDA approved and have not been evaluated for safety, effectiveness, or quality by the FDA
Since many clinics have weight cutoffs before they will even treat a patient, some patients might pursue GLP-1s to meet the requirements, Merhi adds
Ipamorelin is a synthetic growth hormone secretagogue with selective activity